Leuprolide Acetate Requires Prior Authorization

On Feb. 1, 2021, we will begin requiring prior authorization for leuprolide acetate (HCPCS code J1950) for commercial plan members.

If the member received leuprolide acetate in an outpatient setting from Nov. 1, 2020, through Jan. 31, 2021, you don’t need to submit a prior authorization request. The prior authorization coverage of leuprolide acetate, which the member was receiving prior to Feb. 1, 2021, will be effective through July 31, 2021.

How to Submit Prior Authorization

  • Sign in to Link using your Optum ID and select the Prior Authorization and Notification tool.
  • If you don’t have an Optum ID, you can register today.

Please complete all notifications online. If you have questions or need assistance with your online request, call 888-397-8129, 8 a.m. to 5 p.m., Monday through Friday local time.

Questions? Please visit Prior Authorization for Chemotherapy and Related Cancer Therapies.